Laura E. Lantry

1.5k total citations
28 papers, 1.2k citations indexed

About

Laura E. Lantry is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Laura E. Lantry has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Laura E. Lantry's work include Radiopharmaceutical Chemistry and Applications (7 papers), Cancer-related Molecular Pathways (7 papers) and Peptidase Inhibition and Analysis (6 papers). Laura E. Lantry is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Cancer-related Molecular Pathways (7 papers) and Peptidase Inhibition and Analysis (6 papers). Laura E. Lantry collaborates with scholars based in United States, Australia and Germany. Laura E. Lantry's co-authors include Ralph E. Stephens, Jianqing Chen, Adrian D. Nunn, Patricia McAndrew, Anthony A. Amato, Ming You, Jerry R. Mendell, Wendy King, Zarife Sahenk and Thomas W. Prior and has published in prestigious journals such as New England Journal of Medicine, Analytical Biochemistry and Oncogene.

In The Last Decade

Laura E. Lantry

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Lantry United States 18 678 363 265 183 152 28 1.2k
Hua You China 23 605 0.9× 313 0.9× 64 0.2× 128 0.7× 209 1.4× 70 1.5k
Isabel Zvibel Israel 22 620 0.9× 236 0.7× 42 0.2× 494 2.7× 54 0.4× 56 1.6k
Hisashi Hisatomi Japan 19 713 1.1× 171 0.5× 56 0.2× 86 0.5× 60 0.4× 62 1.2k
Jing Tong China 14 597 0.9× 458 1.3× 139 0.5× 45 0.2× 28 0.2× 46 1.0k
Hugh Laverty United Kingdom 10 439 0.6× 95 0.3× 64 0.2× 175 1.0× 105 0.7× 17 1.1k
Inge Tinhofer Austria 22 689 1.0× 427 1.2× 44 0.2× 37 0.2× 329 2.2× 50 1.4k
Zheng Gong China 19 825 1.2× 422 1.2× 44 0.2× 81 0.4× 86 0.6× 42 1.5k
Yasuhiko Kiyozuka Japan 21 532 0.8× 208 0.6× 41 0.2× 142 0.8× 31 0.2× 56 1.1k
Xiaohong Yang China 17 610 0.9× 247 0.7× 42 0.2× 42 0.2× 52 0.3× 56 1.1k
Zeng Fan China 17 609 0.9× 278 0.8× 35 0.1× 108 0.6× 124 0.8× 62 1.2k

Countries citing papers authored by Laura E. Lantry

Since Specialization
Citations

This map shows the geographic impact of Laura E. Lantry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Lantry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Lantry more than expected).

Fields of papers citing papers by Laura E. Lantry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Lantry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Lantry. The network helps show where Laura E. Lantry may publish in the future.

Co-authorship network of co-authors of Laura E. Lantry

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Lantry. A scholar is included among the top collaborators of Laura E. Lantry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Lantry. Laura E. Lantry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cagnolini, Aldo, Jianqing Chen, Laura E. Lantry, et al.. (2010). Automated synthesis, characterization and biological evaluation of [68Ga]Ga-AMBA, and the synthesis and characterization of natGa-AMBA and [67Ga]Ga-AMBA. Applied Radiation and Isotopes. 68(12). 2285–2292. 20 indexed citations
2.
Chen, Jianqing, Weiwei Feng, Aldo Cagnolini, et al.. (2009). 177Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression. Journal of Nuclear Medicine. 50(12). 2017–2024. 69 indexed citations
3.
Thomas, Regi, et al.. (2008). In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues. Clinical & Experimental Metastasis. 26(2). 105–119. 33 indexed citations
4.
Chen, Jianqing, Karen E. Linder, Rolf E. Swenson, et al.. (2008). Biodistribution and efficacy of 177Lu-AMBA in a low GRP receptor expression model of prostate cancer.. 68. 4216–4216. 1 indexed citations
5.
Zhang, Zhongqiu, Yian Wang, Laura E. Lantry, et al.. (2003). Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf. Oncogene. 22(40). 6257–6265. 28 indexed citations
6.
Lantry, Laura E., Zhongqiu Zhang, Keith A. Crist, et al.. (2000). CHEMOPREVENTIVE EFFICACY OF PROMISING FARNESYLTRANSFERASE INHIBITORS. Experimental Lung Research. 26(8). 773–790. 23 indexed citations
7.
8.
Zhang, Zhongqiu, Qing Liu, Laura E. Lantry, et al.. (2000). A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.. PubMed. 60(4). 901–7. 79 indexed citations
9.
10.
Cornwell, David G., et al.. (1998). Cytotoxicity of tocopherols and their quinones in drug‐sensitive and multidrug‐resistant leukemia cells. Lipids. 33(3). 295–301. 46 indexed citations
11.
Lantry, Laura E., Zhongqiu Zhang, Feng Gao, et al.. (1997). Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. Journal of Cellular Biochemistry. 67(S27). 20–25. 29 indexed citations
12.
Lantry, Laura E., et al.. (1996). Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts. Peptides. 17(8). 1397–1403. 33 indexed citations
13.
Vághy, Pál L., et al.. (1995). Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts. Peptides. 16(8). 1367–1373. 26 indexed citations
14.
Hanna, Atef N., et al.. (1995). Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Biochemical Pharmacology. 50(10). 1627–1633. 15 indexed citations
15.
Mallery, Susan R., et al.. (1995). Human microvascular endothelial cell-extracellular matrix interaction in cellular growth state determination. Cell and Tissue Research. 279(1). 37–45. 4 indexed citations
16.
Mendell, Jerry R., John T. Kissel, Anthony A. Amato, et al.. (1995). Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy. New England Journal of Medicine. 333(13). 832–838. 373 indexed citations
17.
Mallery, Susan R., et al.. (1994). Human microvascular endothelial cell-extracellular matrix interaction in cellular growth state determination. Cell and Tissue Research. 279(1). 37–45. 1 indexed citations
18.
Mallery, Susan R., et al.. (1994). Cultured AIDS‐related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities. Journal of Cellular Biochemistry. 56(4). 568–581. 8 indexed citations
19.
Mallery, Susan R., et al.. (1993). Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. Journal of Cellular Biochemistry. 53(4). 360–372. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua You Breakdown of academic impact, for papers by Isabel Zvibel Breakdown of academic impact, for papers by Hisashi Hisatomi Breakdown of academic impact, for papers by Jing Tong Breakdown of academic impact, for papers by Hugh Laverty Breakdown of academic impact, for papers by Inge Tinhofer Breakdown of academic impact, for papers by Zheng Gong Breakdown of academic impact, for papers by Yasuhiko Kiyozuka Breakdown of academic impact, for papers by Xiaohong Yang Breakdown of academic impact, for papers by Zeng Fan
Rankless by CCL
2026